抗血管内皮生长因子（VEGF）疗法治疗中枢神经系统急性髓系白血病复发的疗效：一例病例报告及文献综述
Efficiency of anti-VEGF therapy in central nervous system AML relapse: A case report and literature review.
作者信息
Cao Han-Yu, Tao Tao, Shen Xiang-Dong, Bai Lian, Wan Chao-Ling, Wu De-Pei, Li Jin-Li, Xue Sheng-Li
机构信息
National Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou China.
Institute of Blood and Marrow Transplantation Collaborative Innovation Center of Hematology Soochow University Suzhou China.
出版信息
Clin Case Rep. 2022 Feb 3;10(2):e05367. doi: 10.1002/ccr3.5367. eCollection 2022 Feb.
There have been few reports on the treatment of central nervous system (CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates that bevacizumab may be a viable treatment option when combined with IT chemotherapy as maintenance therapy for those with CNS leukemia.
关于中枢神经系统（CNS）急性髓系白血病（AML）复发的治疗报告较少。本病例研究表明，对于中枢神经系统白血病患者，贝伐单抗与鞘内化疗联合作为维持治疗可能是一种可行的治疗选择。
Zotero 插件